期刊文献+

难治性噬血细胞综合征并发多脏器功能衰竭一例ICU抢救体会

A case of refractory hemophagocytic syndrome combined with multiple organ failure-ICU rescue experience
下载PDF
导出
摘要 噬血细胞综合征(HPS),又名噬血细胞性淋巴组织细胞增多症(HLH),是由活化的淋巴细胞和组织细胞增殖失控并分泌大量炎性细胞因子而引起的过度炎症反应,危及生命。本文介绍1例难治性噬血细胞综合征并发多脏器功能衰竭患者的抢救过程,通过对病史和治疗经过的回顾,抢救时机与细节的分析,挽救性治疗这一理念的实践等方面,探讨重症难治性HPS在重症监护病房(ICU)抢救中的策略与体会。本例患者抢救成功的关键点不仅仅是抓住了初治的早期以及挽救治疗的及时性、有效性,更是与ICU的实时监护和及时有效处理有关。ICU抢救中有效的感染控制和全面的脏器支持可明显改善HPS的阶段性治疗结局,为患者的存活提供可能。 Hemophagocytic syndrome(HPS),also known as hemophagocytic lymphohistiocytosis(HLH),is a lifethreatening condition of severe hyperinflammation caused by the uncontrolled proliferation of activated lymphocytes and histiocytic secreting high amounts of inflammatory cytokines.This article describes a case of refractory hemophagocytic syndrome combined with multiple organ failure.Through the review of medical history and treatment process,analysis of rescue occasion and details,and the practice on the concept of salvage therapy,our purpose is to discuss the strategy and experience that we have gained from rescuing severe refractory hemophagocytic syndrome in ICU.The key to the success rescue of this case is that we not only have carried out timely and effective early stage of initial treatment and salvage treatment,but also have had real-time monitoring and timely and effective treatment in ICU.Based on the effective infection control and comprehensive organ support,the phased treatment results of patients with HPS can be significantly improved,which provides possibility for HPS patients’survival.
出处 《天津医药》 CAS 北大核心 2018年第6期595-599,673,共6页 Tianjin Medical Journal
关键词 噬血细胞性淋巴组织细胞增多症 重症监护病房 多脏器功能衰竭 噬血细胞综合征 挽救性治疗 hemophagocytic lymphohistiocytosis intensive care units multiple organ failure hemophagocytic syndrome salvage therapy
  • 相关文献

参考文献5

二级参考文献90

  • 1James WV, William JG. Hemophagocytic lvmphohistioeytosis diagnosis, pathophysiology, treatment, and future perspectives. Ann Med, 2006, 38 : 20-31.
  • 2Hcnter JI, Home A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2007, 48:124-131.
  • 3Janka GE. Familial and acquired hemophagocytie lymphohistiocylosis. Eur J Pedialr, 2007, 166: 95-109.
  • 4Teng CL, Hwang GY, Lee B J, et al. Pregnancy-induced hemophagocytic lymphohistiocytosis combined with autoimmune hemolytic anemia. J Chin Med Assoc, 2009, 72: 156-159.
  • 5Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytie lymphohistiocytosis. Pediatr Blood Cancer, 2008, 50: 1227-1235.
  • 6Chuang HC, Lay JD, Chuang SE, et al. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome. Am J Pathol, 2007, 170: 1607-1617.
  • 7Henter JI, Home A, Aric6 M, et al. HLH-2004 : Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2007; 48(2) : 124 -131.
  • 8Schneider EM, Lorenz I, Miiller-Rosenberger M, et al. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood, 2002 ; 100 ( 8 ) :2891 - 2898.
  • 9O'Brien MM, Lee-Kim Y, George TI, et al. Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer, 2008 ; 50 ( 2 ) : 381 - 383.
  • 10Bielekova B, Catalfamo M, Reichert-Scrivner S, et al. Regulatory CD56 (bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy ( daclizumab ) in multiple sclerosis. Proc Natl Acad Sci USA, 2006; 103(15) :5941 -5946.

共引文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部